In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

Days after Pfizer and BioNTech reported surprisingly strong sales of their updated COVID-19 vaccines, Moderna has done the ...

For the Pfizer/BioNTech and Moderna vaccines, this means that small changes were made to the mRNA in the vaccine so that the ...

Pfizer and BioNTech have been among the leaders in the race to bring a combined COVID-19 and influenza vaccine to market, but have stumbled in the final straight. The companies reported mixed ...

The CDC recommends that immunocompromised people and those age 65 and older should get a second dose of the 2024-2025 COVID ...

The FDA already has cleared COVID-19 vaccines tweaked to better target omicron as boosters for everyone 5 and older. Pfizer's says its COVID-19 vaccine was 73% effective in protecting children ...

Pfizer PFE COVID revenues have been declining due to lower demand. The company records direct sales and alliance revenues from its partner, BioNTech BNTX, for the COVID-19 vaccine, Comirnaty ...

Pfizer reported third-quarter revenue and adjusted profit that blew past expectations. The company hiked its full-year ...

Pfizer Inc and BioNTech could secure emergency U.S. and European authorization for their COVID-19 vaccine next month after final trial results showed it had a 95% success rate and no serious side ...